Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 153,731 | 67,772 | 61,880 | 42,722 | 42,736 |
| Gross Profit | 153,731 | 67,772 | 61,880 | 42,722 | 42,736 |
| Operating Expenses | 243,009 | 196,715 | 160,404 | 113,779 | 98,204 |
| Operating Income | -89,278 | -128,943 | -98,524 | -71,057 | -55,468 |
| Interest Expense | 11,180 | 3,346 | 3,137 | 3,974 | 4,350 |
| Other Income | 11,857 | 15,585 | -3,877 | 43,006 | 4,074 |
| Pre-tax Income | -88,601 | -116,704 | -105,538 | -32,025 | -55,744 |
| Income Tax | 18,192 | 2,500 | N/A | 103 | N/A |
| Net Income Continuous | -106,793 | -119,204 | -105,538 | -32,128 | -55,744 |
| Net Income | $-106,793 | $-119,204 | $-105,538 | $-32,128 | $-55,744 |
| EPS Basic Total Ops | -1.78 | -2.35 | -2.29 | -0.99 | -2.43 |
| EPS Basic Continuous Ops | -1.78 | -2.35 | -2.29 | -0.99 | -2.43 |
| EPS Diluted Total Ops | -1.78 | -2.35 | -2.29 | -0.99 | -2.43 |
| EPS Diluted Continuous Ops | -1.78 | -2.35 | -2.29 | -0.99 | -2.43 |
| EPS Diluted Before Non-Recurring Items | -1.91 | -2.35 | -2.06 | -2.00 | -2.43 |
| EBITDA(a) | $-91,537 | $-123,617 | $-90,899 | $-66,270 | $-52,148 |